The time has not yet come to remove your chips from the table: Geron Corp (GERN)

With 8.95 million shares changed hands, the volume of the stock remained lighter than its average volume of 11.11 million shares. The 52-week range on GERN shows that it touched its highest point at $5.34 and its lowest point at $1.64 during that stretch. It currently has a 1-year price target of $7.50. Beta for the stock currently stands at 0.46.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GERN was down-trending over the past week, with a drop of -7.89%, but this was down by -14.05% over a month. Three-month performance dropped to -32.01% while six-month performance fell -44.37%. The stock gained 27.86% in the past year, while it has lost -27.40% so far this year. A look at the trailing 12-month EPS for GERN yields -0.32 with Next year EPS estimates of -0.06. For the next quarter, that number is -0.02. This implies an EPS growth rate of 21.15% for this year and 75.35% for next year.

Float and Shares Shorts:

At present, 603.10 million GERN shares are outstanding with a float of 567.45 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GERN since 5 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.11103 being high and -$0.3028 being low. For GERN, this leads to a yearly average estimate of -$0.25233. Based on analyst estimates, the high estimate for the next quarter is -$0.03 and the low estimate is -$0.05. The average estimate for the next quarter is thus -$0.04.